title: [Markers of endothelial dysfunction in patients with iodine induced hyperthyroidism].
abstract: BACKGROUND
  It has been reported that hyperthyroidism is associated with an altered endothelial function and increased risk of arterial thromboembolism. The aim of our study was to estimate chosen markers of endothelial dysfunction in iodine-induced thyrotoxicosis (IIT).
  
  
  METHODS
  The groups studied consisted of 41 hyperthyroid subjects, who had been treated with amiodarone (n = 6) or vitamin preparations supplemented with iodine (n = 35) and 40 persons with normal thyroid function. The following parameters were measured: thyroglobulin antibodies (TG Ab), thyroid peroxidase antibodies (TPO Ab), THS receptor antibodies (TR Ab), soluble adhesion molecules: sVCAM-1 and sICAM-1, von Willebrand factor (vWF), plasminogen activator inhibitor-1 (PAI-1), C-reactive protein (CRP), fibrinogen and urine iodine concentration.
  
  
  RESULTS
  Patients with IIT had significantly higher levels of sVCAM-1 (p < 0.01), IL-6 (p < 0.005), fibrinogen (p < 0.005) and CRP (p < 0.05) in comparison to healthy subjects, whereas sICAM-1, PAI-1 and vWF concentrations did not differ between the groups studied. The highest sVCAM-1 levels were observed in patients with amiodarone induced thyrotoxicosis, and fibrinogen and CRP--in subjects receiving vitamin preparations. There were significant correlations between sVCAM-1 concentration and the levels of sICAM-1 (r = 0.341; p = 0.029) and PAI-1 (r = 0.347; p = 0.026), as well as with urine iodine concentration (r = 0.448; p = 0.004). IL-6 concentration correlated with vWF (r = 0.456; p = 0.003), TPO Ab (r = 0.328; p = 0.036) and PAI-1 level (r = 0.319; p = 0.042).
  
  
  CONCLUSIONS
  Iodine induced thyrotoxicosis is associated with an increase of sVCAM-1 and IL-6 levels, possibly reflecting inflammatory and destructive processes in the thyroid gland. However, increased procoagulant activity was not found in patients with IIT.
authors.affiliation: Department of Endocrinology, Diabetology and Internal Medicine, Medical University, Białystok. zonenbergab@poczta.onet.pl
authors.forename: Anna
authors.initials: A
authors.lastname: Zonenberg
authors.forename: Beata
authors.initials: B
authors.lastname: Telejko
authors.forename: Małgorzata
authors.initials: M
authors.lastname: Szelachowska
authors.forename: Anna
authors.initials: A
authors.lastname: Modzelewska
authors.forename: Agnieszka
authors.initials: A
authors.lastname: Nikołajuk
authors.forename: Maria
authors.initials: M
authors.lastname: Górska
mesh_terms: D000328:Adult; D000368:Aged; D000638:Amiodarone / Q000009:adverse effects; D015415:Biomarkers / Q000097:blood; D042783:Endothelial Cells / Q000378:metabolism*; D004730:Endothelium, Vascular / Q000378:metabolism*; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000097:blood* / Q000139:chemically induced*; D015850:Interleukin-6 / Q000097:blood*; D007455:Iodine / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D012016:Reference Values; D012680:Sensitivity and Specificity; D019010:Vascular Cell Adhesion Molecule-1 / Q000097:blood*
chemical_list: D015415:Biomarkers; D015850:Interleukin-6; D019010:Vascular Cell Adhesion Molecule-1; D007455:Iodine; D000638:Amiodarone